You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 14, 2025

Drugs in MeSH Category Estrogen Antagonists

✉ Email this page to a colleague

« Back to Dashboard

Show entries

Subscribe to access the full database, or Try for Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Actavis Labs Fl Inc	TAMOXIFEN CITRATE	tamoxifen citrate	TABLET;ORAL	076179-002	Feb 20, 2003		DISCN	No	No	⤷ Try for Free	⤷ Try for Free				⤷ Try for Free
Astrazeneca	NOLVADEX	tamoxifen citrate	TABLET;ORAL	017970-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Try for Free	⤷ Try for Free				⤷ Try for Free
Roxane	TAMOXIFEN CITRATE	tamoxifen citrate	TABLET;ORAL	076027-001	Feb 20, 2003		DISCN	No	No	⤷ Try for Free	⤷ Try for Free				⤷ Try for Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.